Testing Spectrosense EVA System for Detection of Breast Cancer by Analyzing Volatile Organic Compounds (VOCs) in Exhaled Air

Status unconfirmed

Conditions studied: Breast Cancer

In brief

Volatile Organic Compounds (VOC) in human breath are captured and analyzed by the Spectrosense EVA system, which is combination of a gas chromatography (GC) and software algorithm. The objective is to obtain a set or sets of VOC bio-markers that will provide the best discrimination between Breast Cancer sick population and healthy population. The gold standard for identifying sick/healthy population is biopsy proven breast cancer.

Key facts

Study ID

NCT01849328

Run by

Rauscher, Gregory E., M.D. PA

People needed

600

Starts

2013-05-01

Last updated by the study team

2013-11-19

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Age from 18 years old
• Breast cancer positive biopsy
• Before any treatment
• Signed Informed Patient Consent

You may not qualify if…

• Age under 18 years old
• Neoadjovant treatment
• Post surgery for breast cancer
• A history of any other cancer type, except skin cancer that is not melanoma
• Healthy group:
• Inclusion Criteria:
• Healthy women
• No history of Breast cancer
• Signed Informed Patient Consent
• Exclusion Criteria:
• History of Breast cancer
• Breast cancer background in the family
• A history of any other cancer type, except skin cancer that is not melanoma

Where it is running

• Englewood Hospital and Medical Center — Englewood, New Jersey, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.